Skyrizi (risankizumab) is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for ...
© TASS, Russian news agency (The Mass Media Registration Certificate No. 03247 was issued on April 2, 1999 by the State Press Committees of the Russian Federation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results